Professor Steven Charlton


Professor Steven Charlton is co-founder of Excellerate Bioscience, as well as Professor of Molecular Pharmacology and Drug Discovery at the University of Nottingham, where he is interested in all aspects of the quantitative assessment of ligand-receptor interactions, particularly the kinetics of binding and signalling. Prior to that he spent 16 years in industry both at SmithKline Beecham and Novartis, where he was Director of Molecular Pharmacology in Respiratory Diseases, leading an assay development and compound profiling team of 30 scientists providing expert opinion and support for GPCR, ion channel and enzyme projects. He has broad drug discovery experience, ranging from target validation through to leading full lead optimisation programmes to successful clinical proof of concept.

Find me on LinkedIn Back to the Team